Department of Oral and Maxillofacial Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
Department of Engineering Science, National Cheng Kung University, Tainan 701, Taiwan.
Biosensors (Basel). 2021 Aug 3;11(8):260. doi: 10.3390/bios11080260.
In recent years, microfluidic lab-on-paper devices have emerged as a rapid and low-cost alternative to traditional laboratory tests. Additionally, they were widely considered as a promising solution for point-of-care testing (POCT) at home or regions that lack medical infrastructure and resources. This review describes important advances in microfluidic lab-on-paper diagnostics for human health monitoring and disease diagnosis over the past five years. The review commenced by explaining the choice of paper, fabrication methods, and detection techniques to realize microfluidic lab-on-paper devices. Then, the sample pretreatment procedure used to improve the detection performance of lab-on-paper devices was introduced. Furthermore, an in-depth review of lab-on-paper devices for disease measurement based on an analysis of urine samples was presented. The review concludes with the potential challenges that the future development of commercial microfluidic lab-on-paper platforms for human disease detection would face.
近年来,微流控纸基芯片实验室设备作为传统实验室检测的一种快速、低成本的替代方法已经出现。此外,它们被广泛认为是在缺乏医疗基础设施和资源的地区或家庭进行即时医疗检测(POCT)的一种很有前途的解决方案。本综述描述了过去五年中用于人体健康监测和疾病诊断的微流控纸基芯片诊断方面的重要进展。综述首先解释了选择纸张、制造方法和检测技术来实现微流控纸基芯片设备的原因。然后,介绍了用于提高纸基芯片设备检测性能的样品预处理程序。此外,还深入回顾了基于尿液样本分析的用于疾病测量的纸基芯片设备。最后,本文探讨了未来用于人体疾病检测的商业化微流控纸基芯片平台发展所面临的潜在挑战。